News Archive

to receive news alerts

2013  
2012  
2011  
2010  
2009  
2008  
2007  
2006  
Wed, 03/29/2006

(Fort Worth, TX) --- H. Paul Dorman, Chairman and CEO of Fort Worth-based DFB Pharmaceuticals, Inc., has announced that DFB has promoted Duncan Aust, Ph.D. to Senior Vice President of Research and Development, Branded Pharmaceuticals, a newly-created position for DFB. Dr. Aust was most recently Vice President of DPT Research and Development, a DFB affiliate headquartered in San Antonio.

Tue, 03/21/2006

(Fort Worth, TX) --- HEALTHPOINT, Ltd., Surgical Division, a DFB Pharmaceuticals, Inc. company, will announce the launch of SURGICEPT™ Waterless Surgical Hand Antiseptic at the Association of periOperative Registered Nurses (AORN) 53rd Congress in Washington, D.C., which begins Tuesday, March 21, 2006. SURGICEPT is the latest member of HEALTHPOINT’s popular, brush free, antisepsis product line.

Thu, 03/16/2006

(Fort Worth, TX) --- Michael E. Steadman, President of Tissue Management for HEALTHPOINT®, Ltd., a DFB Pharmaceuticals, Inc. affiliate company, has announced that Rob Bancroft has been appointed to the position of Senior Vice President, Sales and Marketing for HEALTHPOINT’s Tissue Management Division. Mr. Bancroft was most recently Vice President of Marketing, Tissue Management, a position he has held since joining HEALTHPOINT in November of 2004.

Mon, 03/13/2006

(Fort Worth, Texas) --- HEALTHPOINT’s TheWoundInstitute.com (http://www.thewoundinstitute.com) today announced it has been granted the Recognition Award for Online Continuing Medical Education (CME) Programs from the American Podiatric Medical Association (APMA).

Tue, 03/07/2006

(Fort Worth, TX; Lynbrook, NY) --- HEALTHPOINT, Ltd., a DFB Pharmaceuticals Inc. affiliate company and BioSpecifics Technologies Corp. (BSTC.PK), today announced the sale of BioSpecifics’ topical collagenase business. As part of the agreement, HEALTHPOINT’s affiliate will assume ownership and operation of BioSpecifics’ manufacturing facility in Curaçao and certain other assets in Lynbrook, NY, owned by BioSpecifics’ affiliate, Advance Biofactures Corporation.